BRPI0404983A - composições imunogênicas - Google Patents

composições imunogênicas

Info

Publication number
BRPI0404983A
BRPI0404983A BRPI0404983A BRPI0404983A BR PI0404983 A BRPI0404983 A BR PI0404983A BR PI0404983 A BRPI0404983 A BR PI0404983A BR PI0404983 A BRPI0404983 A BR PI0404983A
Authority
BR
Brazil
Prior art keywords
antigen
days
protein
immunogenic compositions
present
Prior art date
Application number
Other languages
English (en)
Portuguese (pt)
Inventor
Jose Maciel Junior Rodrigues
Karla De Melo Lima
Original Assignee
Nanocore Biotecnologia Ltda
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nanocore Biotecnologia Ltda filed Critical Nanocore Biotecnologia Ltda
Priority to BRPI0404983 priority Critical patent/BRPI0404983A/pt
Priority to PCT/BR2005/000179 priority patent/WO2006024122A1/fr
Priority to EP05782989A priority patent/EP1858547A1/fr
Priority to AU2005279641A priority patent/AU2005279641A1/en
Publication of BRPI0404983A publication Critical patent/BRPI0404983A/pt
Priority to ZA200702752A priority patent/ZA200702752B/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/39Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53DNA (RNA) vaccination
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/545Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/555Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511Organic adjuvants
    • A61K2039/55555Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
BRPI0404983 2004-09-03 2004-09-03 composições imunogênicas BRPI0404983A (pt)

Priority Applications (5)

Application Number Priority Date Filing Date Title
BRPI0404983 BRPI0404983A (pt) 2004-09-03 2004-09-03 composições imunogênicas
PCT/BR2005/000179 WO2006024122A1 (fr) 2004-09-03 2005-09-05 Compositions immunogenes
EP05782989A EP1858547A1 (fr) 2004-09-03 2005-09-05 Compositions immunogènes
AU2005279641A AU2005279641A1 (en) 2004-09-03 2005-09-05 Immunogenic compositions
ZA200702752A ZA200702752B (en) 2004-09-03 2007-04-02 Immunogenic compositions

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
BRPI0404983 BRPI0404983A (pt) 2004-09-03 2004-09-03 composições imunogênicas

Publications (1)

Publication Number Publication Date
BRPI0404983A true BRPI0404983A (pt) 2006-05-02

Family

ID=35999654

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0404983 BRPI0404983A (pt) 2004-09-03 2004-09-03 composições imunogênicas

Country Status (5)

Country Link
EP (1) EP1858547A1 (fr)
AU (1) AU2005279641A1 (fr)
BR (1) BRPI0404983A (fr)
WO (1) WO2006024122A1 (fr)
ZA (1) ZA200702752B (fr)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6461643B2 (en) * 1993-04-22 2002-10-08 Emisphere Technologies, Inc. Oral drug delivery compositions and methods
WO1999016466A2 (fr) * 1997-09-29 1999-04-08 Beth Israel Deaconess Medical Center Compositions de vaccin et procedes servant a augmenter l'efficacite d'un vaccin
AU5006999A (en) * 1998-07-23 2000-02-14 Johns Hopkins University School Of Medicine, The Controlled release of bioactive substances
US6998393B2 (en) * 2000-06-23 2006-02-14 Biopharm Solutions, Inc. Aquespheres, their preparation and uses thereof
EP1478406B1 (fr) * 2002-02-27 2011-01-05 PharmaIN Corporation Compositions pour l'administration de substances therapeutiques et analogues, et procedes de fabrication et d'utilisation desdites compositions

Also Published As

Publication number Publication date
ZA200702752B (en) 2008-09-25
AU2005279641A1 (en) 2006-03-09
EP1858547A1 (fr) 2007-11-28
WO2006024122A1 (fr) 2006-03-09

Similar Documents

Publication Publication Date Title
ES2263668T3 (es) Composicion de vacuna que comprende un antigeno y un peptido con propiedades adyuvantes.
IL238319A0 (en) Isolated or recombinant proteins that stimulate the creation of an immune response against pyogenes.s, preparations that include them and their uses
WO2007089870A3 (fr) Compositions des modes d'administration d'un vaccin et procedes d'utilisation
JP2017525336A5 (fr)
DE60118228D1 (de) Mikropartikel zur verabreichung von heterologen nukleinsäure
IL214460A0 (en) Malaria prime/boost vaccines
BR0103887A (pt) Composições imunogênicas contendo microesferas biodegradáveis encapsulando antìgenos, vetores gênicos e adjuvantes
MXPA06013388A (es) Vector lentiviral recombinante para la expresion de una proteina flaviviridae y sus aplicaciones como vacuna.
WO2007008918A3 (fr) Vaccins de virus comprenant des proteines immunomodulatrices reliees a une enveloppe, et methode d'utilisation associee
JP2006514549A5 (fr)
Gao et al. Protective efficacy of PLGA microspheres loaded with divalent DNA vaccine encoding the ompA gene of Aeromonas veronii and the hly gene of Aeromonas hydrophila in mice
RU2008138535A (ru) Химерные антигены вакцин против вируса птичьего гриппа
BRPI0407840B8 (pt) vírus do sarampo recombinante, composição farmacêutica, uso de uma composição farmacêutica, célula bacteriana, método para produzir um vírus recombinante e uso
MXPA02001223A (es) Proteinas derivadas del virus de sindrome de mancha blanca y usos de las mismas.
WO2005081716A3 (fr) Vaccins adn ciblant des antigenes du coronavirus du syndrome respiratoire aigu severe (sars-cov)
BRPI0404983A (pt) composições imunogênicas
WO2000063406A3 (fr) Vecteurs adenoviraux possedant des acides nucleiques codant pour des molecules immunomodulatrices
JP2012526519A5 (fr)
ATE435660T1 (de) Immunogenes polypeptid bestehend aus optimierten kryptischen peptiden aus tumorantigenen und seine verwendungen
JP5901084B2 (ja) ペプチドアジュバント
BRPI0417286A (pt) misturas de peptìdeos ou polipeptìdeo antigênicos, peptìdeos antigênicos, polipeptìdeo antigênico, misturas antigênicas, lipopeptìdeo, mixotopo, lipomixotopo, conjugado, composições imunogênicas, vacina contra malária, uso de uma mistura, soro policlonal, anticorpo humano recombinante, usos de uma composição, medicamento, métodos e kits para o diagnóstico in vitro de malária, seqüências de nucleotìdeo, vetor de clonagem e/ou expressão recombinante, uso de um vetor de expressão vacina de dna e célula hospedeira recombinante
NZ515330A (en) Lawsonia derived gene and related OmpH polypeptides, peptides and proteins and their uses
CN1809584B (zh) 含有阳离子微粒和hcv e1e2 dna的组合物及其使用方法
WO2002044202A3 (fr) Peptides immunogeniques mutes derives de r9m, polynucleotides les codant et leurs usages therapeutiques
BRPI0604365A (pt) polipeptìdeo isolado, composição de vacina anti-carrapato de múltiplas espécies, e, uso dos mesmos

Legal Events

Date Code Title Description
B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B04C Request for examination: application reinstated [chapter 4.3 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B08E Application fees: payment of additional fee required [chapter 8.5 patent gazette]

Free format text: COMPLEMENTAR 4A., 5A., 6A., 7A. E 8A. ANUIDADES DE ACORDO COM TABELA VIGENTE REF. AS GUIAS NOS. 220708387486, 220807410702, 220906972687, 221006531100 E 220708387486, RESPECTIVAMENTE E COMPROVAR O RECOLHIMENTO DA 3A. ANUIDADE.

B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A TAXA DE RESTAURACAO DA 3A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2249 DE 11/02/2014.